Jacqueline Zummo - Jan 19, 2024 Form 4 Insider Report for Protara Therapeutics, Inc. (TARA)

Signature
/s/ Jacqueline Zummo
Stock symbol
TARA
Transactions as of
Jan 19, 2024
Transactions value $
-$5,824
Form type
4
Date filed
1/23/2024, 04:05 PM
Previous filing
Jan 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TARA Common Stock Award $0 +23K +27.27% $0.00 107K Jan 19, 2024 Direct F1
transaction TARA Common Stock Tax liability -$5.82K -3.05K -2.84% $1.91 104K Jan 19, 2024 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TARA Stock Option (Right to Buy) Award $0 +137K $0.00 137K Jan 19, 2024 Common Stock 137K $1.91 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares being reported are being issued pursuant to restricted stock unit awards (RSUs), each of which represents a contingent right to receive one share of Issuer's common stock. The RSUs vest in equal one-third installments on the first, second and third anniversaries of January 19, 2024.
F2 25% of the shares vest on the one year anniversary of January 19, 2024 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date.
F3 Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 19, 2023.